JP2016520120A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520120A5
JP2016520120A5 JP2016516287A JP2016516287A JP2016520120A5 JP 2016520120 A5 JP2016520120 A5 JP 2016520120A5 JP 2016516287 A JP2016516287 A JP 2016516287A JP 2016516287 A JP2016516287 A JP 2016516287A JP 2016520120 A5 JP2016520120 A5 JP 2016520120A5
Authority
JP
Japan
Prior art keywords
ethyl
tetrahydro
isoquinolin
acetamide
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016516287A
Other languages
English (en)
Japanese (ja)
Other versions
JP6393749B2 (ja
JP2016520120A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/061774 external-priority patent/WO2014191929A1/en
Publication of JP2016520120A publication Critical patent/JP2016520120A/ja
Publication of JP2016520120A5 publication Critical patent/JP2016520120A5/ja
Application granted granted Critical
Publication of JP6393749B2 publication Critical patent/JP6393749B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016516287A 2013-05-30 2014-05-28 Cxcr7受容体調節剤 Expired - Fee Related JP6393749B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2013054478 2013-05-30
IBPCT/IB2013/054478 2013-05-30
PCT/IB2014/061774 WO2014191929A1 (en) 2013-05-30 2014-05-28 Cxcr7 receptor modulators

Publications (3)

Publication Number Publication Date
JP2016520120A JP2016520120A (ja) 2016-07-11
JP2016520120A5 true JP2016520120A5 (cg-RX-API-DMAC10.html) 2017-06-29
JP6393749B2 JP6393749B2 (ja) 2018-09-19

Family

ID=50943357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516287A Expired - Fee Related JP6393749B2 (ja) 2013-05-30 2014-05-28 Cxcr7受容体調節剤

Country Status (30)

Country Link
US (1) US9920010B2 (cg-RX-API-DMAC10.html)
EP (1) EP3004082B1 (cg-RX-API-DMAC10.html)
JP (1) JP6393749B2 (cg-RX-API-DMAC10.html)
KR (1) KR102302580B1 (cg-RX-API-DMAC10.html)
CN (1) CN105263924B (cg-RX-API-DMAC10.html)
AR (1) AR096490A1 (cg-RX-API-DMAC10.html)
AU (1) AU2014272718B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015030095B1 (cg-RX-API-DMAC10.html)
CA (1) CA2912133C (cg-RX-API-DMAC10.html)
CL (1) CL2015003470A1 (cg-RX-API-DMAC10.html)
CY (1) CY1119537T1 (cg-RX-API-DMAC10.html)
DK (1) DK3004082T3 (cg-RX-API-DMAC10.html)
EA (1) EA028604B1 (cg-RX-API-DMAC10.html)
ES (1) ES2645470T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20171597T1 (cg-RX-API-DMAC10.html)
HU (1) HUE036649T2 (cg-RX-API-DMAC10.html)
IL (1) IL242782B (cg-RX-API-DMAC10.html)
LT (1) LT3004082T (cg-RX-API-DMAC10.html)
MA (1) MA38679B1 (cg-RX-API-DMAC10.html)
MX (1) MX364104B (cg-RX-API-DMAC10.html)
MY (1) MY173564A (cg-RX-API-DMAC10.html)
NO (1) NO3004082T3 (cg-RX-API-DMAC10.html)
PH (1) PH12015502632B1 (cg-RX-API-DMAC10.html)
PL (1) PL3004082T3 (cg-RX-API-DMAC10.html)
PT (1) PT3004082T (cg-RX-API-DMAC10.html)
SG (1) SG11201509057UA (cg-RX-API-DMAC10.html)
SI (1) SI3004082T1 (cg-RX-API-DMAC10.html)
TW (1) TWI640510B (cg-RX-API-DMAC10.html)
UA (1) UA118562C2 (cg-RX-API-DMAC10.html)
WO (1) WO2014191929A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
US10202368B2 (en) 2014-12-01 2019-02-12 Idorsia Pharmaceuticals Ltd. CXCR7 receptor modulators
US20170112831A1 (en) * 2015-10-23 2017-04-27 James MERRITT Use of ccr1 antagonists as a treatment for tumors of the central nervous system
EP3490986B1 (en) * 2016-07-28 2021-11-24 Idorsia Pharmaceuticals Ltd Piperidine cxcr7 receptor modulators
AR111808A1 (es) 2017-05-18 2019-08-21 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
EA201992676A1 (ru) 2017-05-18 2020-05-06 Идорсия Фармасьютиклз Лтд Фенильные производные в качестве модуляторов pge2 рецепторов
KR102502046B1 (ko) 2018-01-26 2023-02-20 이도르시아 파마슈티컬스 리미티드 Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-{[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노}-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896170A (en) 1969-02-26 1975-07-22 American Home Prod Intermediates for the preparation of 1,3-dihydro-2h-1, -benzodiazepin-2-ones
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
GB9816984D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
US7256201B2 (en) 2000-12-07 2007-08-14 Astrazeneca Ab Selective estrogen receptor-β ligands
ATE427933T1 (de) 2002-12-20 2009-04-15 Chemocentryx Inc Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
ATE486875T1 (de) * 2005-11-10 2010-11-15 Chemocentryx Inc Substituierte chinolone und verwendungsverfahren
US20100331298A1 (en) 2007-12-10 2010-12-30 Cytopathfinder, Inc. Carboxamide Compounds and Their Use
AR091516A1 (es) * 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
US10202368B2 (en) 2014-12-01 2019-02-12 Idorsia Pharmaceuticals Ltd. CXCR7 receptor modulators

Similar Documents

Publication Publication Date Title
US10195213B2 (en) Chemical entities that kill senescent cells for use in treating age-related disease
HRP20171597T1 (hr) Modulatori cxcr7-receptora
JP2017535618A5 (cg-RX-API-DMAC10.html)
US8481001B2 (en) Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer
ES2660317T3 (es) Combinación de fármacos
JP5490292B2 (ja) 医学的状態を治療するための方法、組成物、およびキット
JP2016510032A5 (cg-RX-API-DMAC10.html)
US20080089859A1 (en) Administration of sleep restorative agents
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
RU2011151277A (ru) Мостиковые производные спиро[2.4]гептана в качестве агонистов рецептора alx и/или fprl2
JPH09511739A (ja) フィブロミアルギアの処置のためのセロトニンアンタゴニスト(5ht▲下3▼)の使用
JP2021512143A5 (cg-RX-API-DMAC10.html)
US11666582B2 (en) Medicament for treating cough
JP2002542287A (ja) 医 薬
RU2013108456A (ru) Пиримидиновые производные, используемые в качестве ингибиторов протеинкиназы
CA2660529A1 (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
RU2007115161A (ru) Новые производные фталазинона в качестве ингибиторов киназы аврора-а
JPS61134314A (ja) 獣医薬鎮静鎮痛剤
RU2008104134A (ru) Кининовые антагонисты для лечения дисфункции мочевого пузыря
US12576083B2 (en) Combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer
JP2023509168A (ja) BTK阻害剤2-[(3R)-3-[4-アミノ-3-(2-フルオロ-4-フェノキシ-フェニル)ピラゾロ[3,4-d]ピリミジン-1-イル]ピペリジン-1-カルボニル]-4-メチル-4-[4-(オキセタン-3-イル)ピペラジン-1-イル]ペンタ-2-エンニトリルを使用する、膜性腎症、IGG4関連疾患、及び抗リン脂質症候群の処置
JP2023542730A (ja) スフィンゴシン-1-リン酸受容体アゴニストの使用
CN1355698A (zh) 可用作治疗有关支气管收缩的机能障碍的药物的化合物
US20050043366A1 (en) Polyamine compounds for treating chemokine receptor mediated diseases
CN1348372A (zh) 药物用途